2 results
Approved WMOPending
This study is being performed to evaluate the cognitive and psychomotor effects of the new compound LY2624803 after bedtime dosing.
Approved WMOCompleted
Can administration of scopolaminebutyl from the start of the dying phase prevent death rattle during the dying phase?